Featured Presentation May 2026 Download PDF Presentations Targeting regulatory RNAs with antisense oligonucleotides enables potentially therapeutically relevant upregulation of gene expression June 23, 2026 Download PDF CMP-002: A Development Candidate Antisense Oligonucleotide Targeting a SYNGAP1 Regulatory RNA For The Potential Treatment of SYNGAP1-Related Disorder June 22, 2026 Download PDF Targeting noncoding regulatory RNAs with antisense oligonucleotides to increase gene expression for the potential treatment of haploinsufficient diseases May 14, 2026 Download PDF American Epilepsy Society Annual Meeting: CMP-002: A Developmental Candidate Antisense Oligonucleotide Targeting a SYNGAP1 Regulatory RNA For The Potential Treatment of SYNGAP1-Related Disorders December 8, 2025 Download PDF Developing Regulatory RNA-based Therapeutics for DEEs and an ASO to Increase SYNGAP Gene Expression September 25, 2025 Download PDF Targeting Regulatory RNAs with Antisense Oligonucleotides for the Potential Treatment of Urea Cycle Disorders May 16, 2025 Download PDF Targeting Regulatory RNAs with Antisense Oligonucleotides for the Potential Treatment of SYNGAP1-Related Disorders May 16, 2025 Download PDF A Phase 1 Study to Evaluate the Safety and Tolerability of an Investigational ASO (CMP-CPS-001) for the Treatment of Urea Cycle Disorders May 16, 2025 Download PDF Keystone Symposia: Interplay of Chromatin Architecture and Transcription Regulation March 26, 2025 Download PDF Transcriptional Characterization of iPSC-Derived Microglia January 25, 2024 Download PDF
